Professor of Medicine/Director, Duke Cancer Institute for Cancer Immunotherapy
From the Duke Cancer Institute:
Translating Findings from a lab into patients in a clinic can be a long slog up a steep hill. The new DCI Center for Cancer Immunotherapy helps researchers with the climb.
It’s August 2019, and Duke Professor of Immunology and Pediatrics Tom Tedder, PhD, is excited; a drug initially developed in his research lab is under review by the US Food and Drug Administration for approval to treat a rare autoimmune disease that affects the central nervous system (neuromyelitis optica.)